September 24, 2020
During the past ten months, much debate has been generated around the world over the drug Hydroxychloroquine, and its use in treating COVID-19. Never in the historical record, has a medical treatment been under such scrutiny or received such controversy. It has become so controversial, several countries including Australia, have banned it from use, and the media is falsely reporting it.
In most countries, Hydroxychloroquine has been used for 70 years as a safe over the shelf anti-malaria drug. Until now.
How have COVID-19 patients around the world been recovering? Countries including China, India, Honduras and Brazil have been successfully using Hydroxychloroquine as a COVID-19 treatment.
Here are some interesting facts
- In 2005 the American Nation Institute of Health SARS Hydroxychloroquine study, revealed “Chloroquine as a potent inhibitor of SARS coronavirus infection and spread”.
- In May 2020, the Lancet published this article, in which 671 hospitals around the world contributed data relating to the use of Hydroxychloroquine with Covid-19 patients.
- Weeks later, the Lancet retracted the study, as the collection company would not provide full access to the information for a third-party peer review.
- In June 2020, The World Health Organisation did the Solidarity Trial, which showed that Hydroxychloroquine was of no benefit for COVID-19 patients.
- The study was regarded as false, due to lethal dosing, not to the standard of safe general practice.
- In July, an American group of Doctors came forward, claiming the drug had benefits for COVID-19 patients. They were soon ridiculed by the Australian press.
- On August 1, the International Journal of Infectious Diseases published this article, which reveals conclusive positive outcomes on the use of the drug.
What is going on?
Is there another agenda?
Follow the money.